Aemetis price to free cash flow AMTX
Market value divided by free cash flow over the last twelve months, since 2014.
- Today, Oct 23, 2026
- n/m
- not a meaningful number
- Last meaningful
- 12.6×
- Mar 2017
- Peer median
- 6.5×
Aemetis' price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.
It was last meaningful in Mar 2017, at 12.6×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2017 | 12.6× | 12.1× | 17.5× |
| 2016 | 14.2× | 14.2× | 164× |
| 2015 | 44.0× | 12.9× | 64.4× |
| 2014 | 22.1× | 15.0× | 82.9× |
Against its peers
Companies in Chemicals - Specialty nearest Aemetis' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| AMTXAemetis | n/m |
| ALTOAlto Ingredients | 5.6× |
| LXFRLuxfer | 27.9× |
| LXULSB Industries | 7.3× |
| WLKPWestlake Chemical Partners | 1.8× |
| Peer median | 6.5× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Aemetis
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.